Global biopharmaceutical company and strategic co-investor, co-launching a $50M seed fund with UPenn to back early-stage life science startups from university research.

Mainz, Germany · 1+ investments

Seed
Early Stage
Biotech
Infectious Disease
Life Sciences
Oncology
Headquarters
Mainz, Germany
Founded
2008
Total Investment
1
Last Investment
Feb 2025
Geographic Focus
United States

Investment Thesis

Deepens R&D collaborations by co-investing in early-stage life science startups emerging from leading research universities, focusing on mRNA, immunotherapy, and next-generation therapeutics.

BioNTech is a Venture Capital firm based in Mainz, Germany. It has made 1 investment in Biotech and Infectious Disease.

Investment History

Sign up to view investment history

Create a free account — 10 credits a month to unlock deal history, amounts, and round details.

BioNTech — Investor Profile & Portfolio | Indexed.vc